pseudomyxoma peritonei (Cancer)
Information
- Disease name
- pseudomyxoma peritonei
- Disease ID
- DOID:3559
- Description
- "An appendix cancer that is characterized by progressive accumulation of mucus-secreting tumor cells within the abdomen and pelvis." [url:http\://en.wikipedia.org/wiki/Pseudomyxoma_peritonei, url:http\://www.cancer.gov/dictionary?CdrID=44256, url:http\://www.rarediseases.org/rare-disease-information/rare-diseases/byID/843/viewAbstract, url:https\://www.ncbi.nlm.nih.gov/pubmed/14567019]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT02387203 | Active, not recruiting | Phase 2 | Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin | January 2015 | December 2024 |
NCT02834013 | Active, not recruiting | Phase 2 | Nivolumab and Ipilimumab in Treating Patients With Rare Tumors | January 30, 2017 | May 1, 2026 |
NCT01764789 | Completed | N/A | Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer | October 2010 | January 2012 |
NCT02040142 | Completed | Phase 2 | Single Arm Study Treating Patients of Peritoneal Surface Malignancy (Colorectal, Appendical, Pseudomyxoma, Gastric) With Cytoreductive Surgery and Hyperthermic Intraperitoneal Mitomycin-C | November 2011 | November 9, 2020 |
NCT01126346 | Completed | N/A | Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | May 2010 | October 2013 |
NCT01652794 | Completed | Phase 1 | Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer | May 2012 | March 2015 |
NCT02374411 | Completed | Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients | September 2014 | March 2015 | |
NCT02949791 | Completed | Phase 2 | HIPEC Using High Intra-abdominal Pressure | December 2014 | November 2017 |
NCT03034850 | Completed | Thrombin Generation and Platelet Activation in CRS/HIPEC | April 2015 | July 2016 | |
NCT04088786 | Completed | Phase 1 | Phase I Trial HIPEC With Nal-irinotecan | October 22, 2019 | April 14, 2022 |
NCT05513183 | Completed | Severe Neutropenia After HIPEC Using Mitomycin-C | May 20, 2021 | March 20, 2023 | |
NCT06084780 | Not yet recruiting | Phase 2 | Intestinal & Multivisceral Transplantation for Unresectable Mucinous Carcinoma Peritonei (TRANSCAPE) | October 2024 | December 31, 2025 |
NCT02599116 | Recruiting | N/A | Gastrointestinal Microbiome Study of Appendiceal Cancer | December 2015 | December 2024 |
NCT02073500 | Recruiting | Peritoneal Surface Malignancies - Characterization, Models and Treatment Strategies | September 2009 | August 2027 | |
NCT01617382 | Recruiting | Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed | May 2012 | December 2026 | |
NCT04024917 | Recruiting | N/A | Impact of Cardiac Coherence on Anxiety in Patients Operated on for a Peritoneal Carcinosis | September 21, 2021 | June 2025 |
NCT04665921 | Terminated | Phase 1 | A Study of SGN-STNV in Advanced Solid Tumors | January 18, 2021 | March 1, 2024 |
NCT01427101 | Unknown status | Results of CRS and Debulking in PMP Patients | September 1993 | ||
NCT04982146 | Unknown status | Phase 1 | Intratumoral Bromelain + Acetylcysteine in Relapsed and Unresectable Pseudomyxoma Peritonei | September 13, 2021 | May 16, 2023 |
NCT05321329 | Unknown status | Phase 2 | Adjuvant CAPECITABINE in High Risk PSEUDOMYXOMA PERITONEI Patients | December 3, 2018 | December 2023 |
NCT03210298 | Unknown status | International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) | January 2016 | September 2022 | |
NCT03976973 | Unknown status | Phase 2 | BromAc for Recurrent Peritoneal Mucinous Tumour or Pseudomyxoma Peritonei | May 2022 | February 2024 |
NCT02834169 | Unknown status | French National Registry of Rare Peritoneal Surface Malignancies | October 2010 | December 2018 | |
NCT04125225 | Withdrawn | What Are the Experiences of Patients With Pseudomyxoma Peritonei? | November 1, 2019 | February 1, 2021 |
- Disase is a (Disease Ontology)
- DOID:11239
- Cross Reference ID (Disease Ontology)
- GARD:7488
- Cross Reference ID (Disease Ontology)
- ICDO:8480/6
- Cross Reference ID (Disease Ontology)
- MESH:D011553
- Cross Reference ID (Disease Ontology)
- NCI:C3345
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:307601000
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0033822
- Exact Synonym (Disease Ontology)
- mucinous Ascites
- OrphaNumber from OrphaNet (Orphanet)
- 26790
- MeSH unique ID (MeSH (Medical Subject Headings))
- D011553